Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Emergent Biosolutions Inc’s current trading price is 1.10% away from its 52-week high, while its distance from the 52-week low is 940.14%. The stock’s price range during this period has varied between $1.42 and $14.61. The company, active in the Healthcare sector, saw a trading volume of around 1.74 million for the day, considerably lower average daily volume of 5.44 million observed over the last three months.
In terms of market performance, Emergent Biosolutions Inc had a somewhat regular. The highest value for the stock in the past year was $14.61 on 07/29/24, while the lowest value was $1.42 on 02/06/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
How Financial Performance Impacts Market Capitalization
Emergent Biosolutions Inc (EBS) has experienced a quarterly rise of 669.27% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 773.95M and boasts a workforce of 1600 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.30, with a change in price of +11.36. Similarly, Emergent Biosolutions Inc recorded 3,920,490 in trading volume during the last 100 days, posting a change of +333.14%.
How EBS’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for EBS stands at 1.39. Similarly, the long-term debt-to-equity ratio is also 0.69.
EBS Stock Stochastic Average
As of today, the raw stochastic average of Emergent Biosolutions Inc over the past 50 days is 96.94%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 96.14%. Additionally, the Stochastic %K and %D values for the company were 92.77% and 93.64%, respectively, over the past 20 days.
EBS Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Year to date metric has recorded a gain of 515.42%.However, over the last six months, we can see a weaker performance of 711.54%. Over the last 30 days, the price of EBS has fallen by 111.60%. And in the last five days, it has surged by 28.88%.
